Skip to Content

Endo 607 (Carbidopa and levodopa 25 mg / 250 mg)

Pill imprint Endo 607 has been identified as Carbidopa and levodopa 25 mg / 250 mg.

Carbidopa/levodopa is used in the treatment of restless legs syndrome; parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Carbidopa and levodopa 25 mg / 250 mg Endo 607  Front
Carbidopa and levodopa 25 mg / 250 mg Endo 607  Back
Carbidopa and levodopa 25 mg / 250 mg Endo 607
Discount Card Promo
Carbidopa and levodopa
Imprint:
Endo 607
Strength:
25 mg / 250 mg
Color:
Blue
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Endo Pharmaceuticals Inc.
National Drug Code (NDC):
60951-0607

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide